Pfizer PFE
NYSE PFE
$29.44 +0.08 (+0.27%)
At close: Nov 11, 2026 · 4:00 PM EST

Pfizer (PFE) Total Non-Current Liabilities (2009 - 2026)

Updated

Pfizer's Total Non-Current Liabilities was $96.04 billion in Q3 2026, down 2.9% from $98.9 billion a year earlier and down 1.0% from the prior quarter.

Analysis

Pfizer (PFE) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

At the end of FY2025, Total Non-Current Liabilities at Pfizer came in at $103.07 billion, down 1.5% from FY2024.

  • Total Non-Current Liabilities shows a five-year compound annual growth rate of 7.3% (FY2020 to FY2025).
  • In earlier years, Total Non-Current Liabilities was $104.64 billion in FY2024 (-7.1%), $112.64 billion in FY2023 (+43.9%), $78.3 billion in FY2022 (-5.6%) and $82.94 billion in FY2021 (+14.4%).
  • The Q3 2026 figure marks the lowest quarterly Total Non-Current Liabilities since Q3 2023.
  • Compared with a year earlier, Total Non-Current Liabilities was higher in 1 of the last eight quarters, with an average decline of 3.8%.
  • The best year-over-year quarter for Total Non-Current Liabilities over five years was Q1 2024 (growth of 45.8%); the worst was Q1 2023 (a decline of 9.3%).
  • Per Business Quant data, PFE's Total Non-Current Liabilities in the three quarters before Q3 2026 was $97.04 billion (Q2 2026), $99.69 billion (Q1 2026) and $103.07 billion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 60.81 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 102.65 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 117.60 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 79.95 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -36.84 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 36.05 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 96.04 Bn
10 Vertex Pharmaceuticals 138.90 Bn 106.64 Bn 2.91 Bn 10.48 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 27, 2026 96.04 Bn
Jun 28, 2026 97.04 Bn
Mar 29, 2026 99.69 Bn
Dec 31, 2025 103.07 Bn
Sep 28, 2025 98.90 Bn
Jun 29, 2025 99.84 Bn
Mar 30, 2025 98.37 Bn
Dec 31, 2024 104.64 Bn
Sep 29, 2024 105.44 Bn
Jun 30, 2024 105.59 Bn
Mar 31, 2024 104.81 Bn
Dec 31, 2023 112.64 Bn
Oct 1, 2023 95.48 Bn
Jul 2, 2023 99.42 Bn
Apr 2, 2023 71.90 Bn
Dec 31, 2022 78.30 Bn
Oct 2, 2022 80.52 Bn
Jul 3, 2022 85.52 Bn
Apr 3, 2022 79.23 Bn
Dec 31, 2021 82.94 Bn
API Access

Pfizer Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=PFE&period=max&api_key=YOUR_API_KEY